AU2001238493A1 - Methods and compositions for the identification, assessment, prevention and therapy of human cancers - Google Patents
Methods and compositions for the identification, assessment, prevention and therapy of human cancersInfo
- Publication number
- AU2001238493A1 AU2001238493A1 AU2001238493A AU3849301A AU2001238493A1 AU 2001238493 A1 AU2001238493 A1 AU 2001238493A1 AU 2001238493 A AU2001238493 A AU 2001238493A AU 3849301 A AU3849301 A AU 3849301A AU 2001238493 A1 AU2001238493 A1 AU 2001238493A1
- Authority
- AU
- Australia
- Prior art keywords
- assessment
- therapy
- prevention
- compositions
- identification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G01N33/575—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18331200P | 2000-02-17 | 2000-02-17 | |
| US60/183,312 | 2000-02-17 | ||
| PCT/US2001/005263 WO2001061048A2 (en) | 2000-02-17 | 2001-02-16 | Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001238493A1 true AU2001238493A1 (en) | 2001-08-27 |
Family
ID=22672288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001238493A Abandoned AU2001238493A1 (en) | 2000-02-17 | 2001-02-16 | Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020051978A1 (en) |
| AU (1) | AU2001238493A1 (en) |
| WO (1) | WO2001061048A2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070166704A1 (en) * | 2002-01-18 | 2007-07-19 | Fei Huang | Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| CN102989009B (en) * | 2003-12-31 | 2015-06-03 | 宾夕法尼亚州研究基金会 | Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| US7183257B2 (en) * | 2004-04-14 | 2007-02-27 | The Brigham And Women's Hospital, Inc. | Use of RPL41 to treat infections and inhibit cancer |
| US20060121511A1 (en) * | 2004-11-30 | 2006-06-08 | Hyerim Lee | Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents |
| BRPI0518884A2 (en) * | 2004-12-08 | 2008-12-30 | Aventis Pharma Inc | Method for measuring resistance or sensitivity to docetaxel |
| CA2596469A1 (en) * | 2005-02-01 | 2006-08-10 | Government Of The U.S.A, As Represented By The Secretary Department Of H Ealth & Human Services | Biomarkers for tissue status |
| US20070218487A1 (en) * | 2006-03-03 | 2007-09-20 | University Of Southern California | Genetic markers for predicting disease and treatment outcome |
| WO2008011046A2 (en) * | 2006-07-17 | 2008-01-24 | The H.Lee Moffitt Cancer And Research Institute, Inc. | Computer systems and methods for selecting subjects for clinical trials |
| EP2115163A2 (en) * | 2007-01-18 | 2009-11-11 | University Of Southern California | Gene polymorphisms as sex-specific predictors in cancer therapy |
| WO2008115561A2 (en) * | 2007-03-21 | 2008-09-25 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents |
| JP5606438B2 (en) * | 2008-07-23 | 2014-10-15 | エフ.ホフマン−ラ ロシュ アーゲー | Identification of subjects who can receive anti-angiogenic therapy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736326A (en) * | 1987-05-05 | 1998-04-07 | City Of Hope | Method of detecting resistance to chemo therapeutic agents in cancer patients |
-
2001
- 2001-02-16 US US09/788,100 patent/US20020051978A1/en not_active Abandoned
- 2001-02-16 WO PCT/US2001/005263 patent/WO2001061048A2/en not_active Ceased
- 2001-02-16 AU AU2001238493A patent/AU2001238493A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001061048A2 (en) | 2001-08-23 |
| US20020051978A1 (en) | 2002-05-02 |
| WO2001061048A3 (en) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002322280A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001236519A1 (en) | Identification, assessment, prevention, and therapy of prostate cancer | |
| AU6147401A (en) | Compositions and methods for the treatment of cancer | |
| AU2001251613A1 (en) | Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers | |
| AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002219782A1 (en) | Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2001245295A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU7701100A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| IL158206A0 (en) | Compositions and methods for the prevention and treatment of human prostate cancer | |
| AU2002257033A1 (en) | Agents and methods for the prevention of initial onset and recurrence of existing cancers | |
| AU2001238493A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2074101A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| AU2596901A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2002241720A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer |